PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes
返回论文页
Full-length article|更新时间:2023-08-29
|
PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes
PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes
Genes & Diseases2023年10卷第5期
作者机构:
1. Department of Clinical Laboratory, Children's Hospital of Chongqing Medical University,Chongqing,China,400014
2. Department of Pediatric Research Institute, Children's Hospital of Chongqing Medical University,Chongqing,China,400014
3. Department of Cardiovascular (Internal Medicine), Children's Hospital of Chongqing Medical University,Chongqing,China,400014
4. Chongqing Key Laboratory of Pediatrics,Chongqing,China,400014
Huiwen Liu, Yanting Sun, Hao Xu, 等. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes[J]. Genes & Diseases, 2023,10(5).
Huiwen Liu, Yanting Sun, Hao Xu, et al. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes[J]. Genes & Diseases, 2023,10(5).
Huiwen Liu, Yanting Sun, Hao Xu, 等. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.08.023.
Huiwen Liu, Yanting Sun, Hao Xu, et al. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.08.023.
PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes
摘要
Abstract
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have attracted attention in the field of regenerative medicine due to their potential ability to repair damaged hearts. However
the immature phenotype of these cells limits their clinical application. Cardiomyocyte maturation is accompanied by changes in mitochondrial quality. PTEN-induced putative kinase 1 (PINK1) has been linked to mitochondrial quality control. However
whether the changes in mitochondrial quality in hiPSC-CMs are associated with PINK1
and the impact of PINK1 on hiPSC-CMs development are not clear. In this study
we found that knockdown of PINK1 in hiPSC-CMs resulted in mitochondrial fragmentation and impaired mitochondrial functions such as mitophagy and mitochondrial biogenesis. PINK1 deletion also inhibited the maturation of hiPSC-CMs
reverting them to a naive structural and functional state. We found that restoring the mitochondrial structure did not completely rescue the mitochondrial dysfunction caused by PINK1 deletion
while activation of PINK1 kinase activity using kinetin promoted mitochondrial fusion
increased the mitochondrial membrane potential and ATP production
and maintained the development and maturation of hiPSC-CMs. In conclusion
PINK1 regulates the mitochondrial structure and function of hiPSC-CMs
PGC-1α promotes mitochondrial respiration and biogenesis during the differentiation of hiPSCs into cardiomyocytes
相关作者
Qin Zhou
Hao Xu
Liang Yan
Liang Ye
Xinyuan Zhang
Bin Tan
Qin Yi
Jie Tian
相关机构
Department of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders National Clinical Research Center for Child Health and Disorders (Chongqing) China International Science and Technology Cooperation Base of Child Development and Critical Disorders Children’s Hospital of Chongqing Medical University
Chongqing Key Laboratory of Pediatrics
Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Department of Clinical Laboratory Ministry of Education Key Laboratory of Child Development and Disorders National Clinical Research Center for Child Health and Disorders (Chongqing) China International Science and Technology Cooperation Base of Child Development and Critical Disorders Children’s Hospital of Chongqing Medical University
Department of Cardiovascular (Internal Medicine), Ministry of Education Key Laboratory of Child Development and Disorders National Clinical Research Center for Child Health and Disorders (Chongqing) China International Science and Technology Cooperation Base of Child Development and Critical Disorders Children’s Hospital of Chongqing Medical University